Immunosuppressive Nanoparticles for Management of Immune-Related Adverse Events in Liver
出版年份 2021 全文链接
标题
Immunosuppressive Nanoparticles for Management of Immune-Related Adverse Events in Liver
作者
关键词
-
出版物
ACS Nano
Volume -, Issue -, Pages -
出版商
American Chemical Society (ACS)
发表日期
2021-05-14
DOI
10.1021/acsnano.1c02391
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Mechanisms of checkpoint inhibition‐induced adverse events
- (2020) P. Urwyler et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Top 10 Challenges in Cancer Immunotherapy
- (2020) Priti S. Hegde et al. IMMUNITY
- Fatal Adverse Events Associated With Programmed Cell Death Ligand 1 Inhibitors: A Systematic Review and Meta-Analysis
- (2020) Xuewen Wang et al. Frontiers in Pharmacology
- Engineered PD‐L1‐Expressing Platelets Reverse New‐Onset Type 1 Diabetes
- (2020) Xudong Zhang et al. ADVANCED MATERIALS
- The 2016–2019 ImmunoTOX assessment board report of collaborative management of immune-related adverse events, an observational clinical study
- (2020) Jean-Marie Michot et al. EUROPEAN JOURNAL OF CANCER
- Moving towards personalized treatments of immune-related adverse events
- (2020) Khashayar Esfahani et al. Nature Reviews Clinical Oncology
- Immune-related adverse events of checkpoint inhibitors
- (2020) Manuel Ramos-Casals et al. Nature Reviews Disease Primers
- The dose threshold for nanoparticle tumour delivery
- (2020) Ben Ouyang et al. NATURE MATERIALS
- Spectrum and impact of checkpoint inhibitor-induced irAEs
- (2020) Laura C. Cappelli et al. Nature Reviews Rheumatology
- Liver damage related to immune checkpoint inhibitors
- (2019) Naoshi Nishida et al. Hepatology International
- Biomimetic Nanotechnology toward Personalized Vaccines
- (2019) Jiarong Zhou et al. ADVANCED MATERIALS
- Adverse Events Following Cancer Immunotherapy: Obstacles and Opportunities
- (2019) Kristen E. Pauken et al. TRENDS IN IMMUNOLOGY
- Review article: immune checkpoint inhibitors and the liver, from therapeutic efficacy to side effects
- (2019) Andrea Lombardi et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Red blood cell–derived nanoerythrosome for antigen delivery with enhanced cancer immunotherapy
- (2019) Xiao Han et al. Science Advances
- Chronic inflammation in the etiology of disease across the life span
- (2019) David Furman et al. NATURE MEDICINE
- Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis
- (2018) Javid J Moslehi et al. LANCET
- Gastrointestinal toxicity of immune checkpoint inhibitors: from mechanisms to management
- (2018) Mark A. Samaan et al. Nature Reviews Gastroenterology & Hepatology
- Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
- (2018) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- Cytokines in clinical cancer immunotherapy
- (2018) Pedro Berraondo et al. BRITISH JOURNAL OF CANCER
- A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization
- (2018) Miguel F. Sanmamed et al. CELL
- Therapeutic T cell engineering
- (2017) Michel Sadelain et al. NATURE
- PD-L1 genetic overexpression or pharmacological restoration in hematopoietic stem and progenitor cells reverses autoimmune diabetes
- (2017) Moufida Ben Nasr et al. Science Translational Medicine
- Mesenchymal stromal cells inhibit CD25 expression via the mTOR pathway to potentiate T-cell suppression
- (2017) Hyun Seung Yoo et al. Cell Death & Disease
- Suppression of Hepatic Inflammation via Systemic siRNA Delivery by Membrane-Disruptive and Endosomolytic Helical Polypeptide Hybrid Nanoparticles
- (2016) Hua He et al. ACS Nano
- Immune-related adverse events with immune checkpoint blockade: a comprehensive review
- (2016) J.M. Michot et al. EUROPEAN JOURNAL OF CANCER
- Transplantation with autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: Phase 2 trial
- (2016) Ki Tae Suk et al. HEPATOLOGY
- Nanoparticle–liver interactions: Cellular uptake and hepatobiliary elimination
- (2016) Yi-Nan Zhang et al. JOURNAL OF CONTROLLED RELEASE
- Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination
- (2016) Celine Boutros et al. Nature Reviews Clinical Oncology
- PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
- (2016) Weiping Zou et al. Science Translational Medicine
- Mesenchymal Stromal Cell Secretion of Programmed Death-1 Ligands Regulates T Cell Mediated Immunosuppression
- (2016) Lindsay C. Davies et al. STEM CELLS
- Unbalanced Immune System: Immunodeficiencies and Autoimmunity
- (2016) Giuliana Giardino et al. Frontiers in Pediatrics
- Treatment of the Immune-Related Adverse Effects of Immune Checkpoint Inhibitors
- (2016) Claire F. Friedman et al. JAMA Oncology
- The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine
- (2013) Paolo Bianco et al. NATURE MEDICINE
- Visualizing Dynamics of Sub-Hepatic Distribution of Nanoparticles Using Intravital Multiphoton Fluorescence Microscopy
- (2012) Shih-Hsun Cheng et al. ACS Nano
- Mesenchymal Stromal Cells: New Directions
- (2012) Armand Keating Cell Stem Cell
- A protocol for isolation and culture of mesenchymal stem cells from mouse bone marrow
- (2009) Masoud Soleimani et al. Nature Protocols
- Regulatory T Cells and Inflammation: Better Late Than Never
- (2008) Steven F. Ziegler IMMUNITY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started